J. Cline to Mice, Transgenic
This is a "connection" page, showing publications J. Cline has written about Mice, Transgenic.
Connection Strength
0.142
-
Flores A, Argetsinger LS, Stadler LKJ, Malaga AE, Vander PB, DeSantis LC, Joe RM, Cline JM, Keogh JM, Henning E, Barroso I, Mendes de Oliveira E, Chandrashekar G, Clutter ES, Hu Y, Stuckey J, Farooqi IS, Myers MG, Carter-Su C. Crucial Role of the SH2B1 PH Domain for the Control of Energy Balance. Diabetes. 2019 11; 68(11):2049-2062.
Score: 0.040
-
Fang X, Gyabaah K, Nickkholgh B, Cline JM, Balaji KC. Novel In Vivo model for combinatorial fluorescence labeling in mouse prostate. Prostate. 2015 Jun 15; 75(9):988-1000.
Score: 0.030
-
Maglic D, Stovall DB, Cline JM, Fry EA, Mallakin A, Taneja P, Caudell DL, Willingham MC, Sui G, Inoue K. DMP1ß, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer. J Pathol. 2015 May; 236(1):90-102.
Score: 0.029
-
Davis VL, Shaikh F, Gallagher KM, Villegas M, Rea SL, Cline JM, Hughes CL. Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ER?3, a dominant negative estrogen receptor a variant. Horm Cancer. 2012 Dec; 3(5-6):227-39.
Score: 0.025
-
Luke CT, Oki-Idouchi CE, Cline JM, Lorenzo PS. RasGRP1 overexpression in the epidermis of transgenic mice contributes to tumor progression during multistage skin carcinogenesis. Cancer Res. 2007 Nov 01; 67(21):10190-7.
Score: 0.018